Objective There is no definitive guideline for the significance and cut-off value of squamous-
cell carcinoma antigen (SCC-Ag) in cervical cancer. Thus, we analyzed the significance and …

Objective To analyze the association between posttreatment squamous cell carcinoma
antigen (SCC Ag) and treatment failure in patients with cervical SCC treated with concurrent …

Objective The aim of the present study was to assess prognostic factors for patients with
locally advanced cervical cancer treated with radiotherapy as the primary treatment and to …

Purpose Although the role of squamous cell carcinoma antigen (SCC-Ag) as a predictive
and prognostic factor for uterine cervical cancer has been identified in previous studies, 1) …

The value of squamous-cell carcinoma antigen (SCC-Ag) as a tumor marker for cervical
cancer is controversial because it is not elevated (> 2 ng/mL) in a quarter of patients at …

At present, the standard treatment approach for locally advanced cervical cancer is
concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma …

Objective The aim of this study was to evaluate the prognostic value of squamous cell
carcinoma antigen (SCC-Ag) and the optimal cut-off value for predicting recurrence in …

The purpose of this study was to determine the pretreatment serum squamous cell
carcinoma antigen (SCC-ag) level as a generally applicable measurement in predicting and …

Objective To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag)
levels upon the diagnosis of recurrent cervical cancer for decision making in patient …

Objective The aim of this study was to assess the potential benefit of routine squamous cell
carcinoma antigen (SCC-Ag) assessment during follow-up of patients after treatment for …